Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
about
Undiagnosed MODY: Time for ActionIdentification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.Reclassification of diabetes etiology in a family with multiple diabetes phenotypesExamination of Rare Variants in HNF4 α in European Americans with Type 2 DiabetesMaturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families.Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model.A Single Nucleotide Variant in HNF-1β is Associated with Maturity-Onset Diabetes of the Young in a Large Chinese Family.Clinically-Defined Maturity Onset Diabetes of the Young in Omanis: Absence of the common Caucasian gene mutations.Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.Mutations in HNF1A Gene are not a Common Cause of Familial Young-Onset Diabetes in Iran.In vivo measurement and biological characterisation of the diabetes-associated mutant insulin p.R46Q (GlnB22-insulin).The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives.
P2860
Q28083025-EC2FB637-DD6F-44FA-B47E-38F5057081BEQ34228428-7E197A48-38EE-4B62-B1CC-F8CA67132BC2Q34294841-EF5A6AF0-77B4-4A61-9774-66F51EA76565Q36447511-ED3333F0-D1BE-4439-9785-7D268D2A854CQ37364911-E4DB6AB7-673B-4DC2-89A3-855824589CABQ37619901-53DC59CE-9BD2-42C2-8BD7-6378F9308AAEQ40525737-A967842D-9AF9-444A-84D8-5F5ABF001692Q42714781-84BBFAA5-139E-4338-AD97-D365A35285ACQ43805190-10C19768-7543-46E5-9EF5-03F3651CA317Q45981116-02D39D7B-3C51-46A7-BF80-840FC8CD6FC6Q49679341-22205017-FF9F-4963-8306-2D1F17D97A51Q50646974-14E68FBC-0EC1-4B58-A6C1-B8F30A090256Q51367093-7CBB1318-ACC5-4E12-AD3F-ED70B1BB0359Q51469456-D9489997-4923-4A3F-A929-49A0343938D6Q54267275-48317E01-D4A0-47ED-A877-8EE6DBB880F7Q54973025-00A30E53-AB49-41A7-A97D-65E51511AB40
P2860
Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Half of clinically defined mat ...... tions in HNF4A, GCK, and TCF1.
@en
Half of clinically defined mat ...... tions in HNF4A, GCK, and TCF1.
@nl
type
label
Half of clinically defined mat ...... tions in HNF4A, GCK, and TCF1.
@en
Half of clinically defined mat ...... tions in HNF4A, GCK, and TCF1.
@nl
prefLabel
Half of clinically defined mat ...... tions in HNF4A, GCK, and TCF1.
@en
Half of clinically defined mat ...... tions in HNF4A, GCK, and TCF1.
@nl
P2093
P356
P1476
Half of clinically defined mat ...... tions in HNF4A, GCK, and TCF1.
@en
P2093
P304
P356
10.1210/JC.2005-0196
P407
P577
2005-05-31T00:00:00Z